![Chemical structure of N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide, CAS 23672-07-3](https://api.angenesci.com/structure/1289/23672-07-3.png)
无数据
无数据
无数据
| CAS Number | 23672-07-3 |
| Catalog Number | AG002O30(AGN-PC-0QZSWN) |
| Chemical Name | N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide |
| IUPAC Name | N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide |
| InChI | InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)/t11-/m0/s1 |
| InChI Key | BGRJTUBHPOOWDU-NSHDSACASA-N |
| MDL Number | MFCD00055220 |
| Molecular Formula | C15H23N3O4S |
| Molecular Weight | 341.4258 |
| SMILES | NS(=O)(=O)C=1C=CC(=C(C(=O)NC[C@H]2N(CCC2)CC)C1)OC |
| UNII | JTG7R315LK |
| Synonyms | levopraid,
levosulpiride,
N-(((S)-1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide,
RV-12309,
Levosulpiride,
23672-07-3,
(-)-Sulpiride,
(S)-(-)-sulpiride,
Levopraid,
S-(-)-Sulpiride,
Levosulpirida,
Levosulpiridum,
(S)-sulpiride,
UNII-JTG7R315LK,
RV-12309,
JTG7R315LK,
Levobren,
L-Sulpiride,
CHEBI:64119,
(S)-(-)-N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide,
(S)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoylbenzamide,
S-(-)-N-(1-Ethyl-2-pyrrolidinomethyl)-2-methoxy-5-sulfamoylebenzamide,
MFCD00055220,
NCGC00024853-05,
(-)-N-(((S)-1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide,
N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide,
N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide,
(S)-(-)-5-aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide,
DSSTox_CID_22583,
DSSTox_RID_80052,
DSSTox_GSID_42583,
Levopride,
Nexipride,
(S)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide,
SMR000466366,
CAS-23672-07-3,
SULPIRIDE,(+),
Levogastrol,
Levosulpride,
Sulpid,
Sulpiride-l,
S-Sulpiride,
Sulpiride-S,
(S)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide,
N-[((2S)-1-ethylpyrrolidin-2-yl)methyl](6-methoxy-3-sulfamoylphenyl)carboxamid e,
Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoyl-, S-(-)-,
Levopraid (TN),
CAS-15676-16-1,
Tocris-0895,
levosulpiride-levogastrol,
Sulpiride [L-(-)],
AC1LELQ0,
Biomol-NT_000030,
Levosulpiride (Levogastrol),
Lopac0_001089,
SCHEMBL70112,
GTPL958,
MLS000759490,
MLS001424014,
BPBio1_001221,
CHEMBL267044,
DTXSID0042583,
BDBM81774,
CTK8B3281,
ZINC57008,
BGRJTUBHPOOWDU-NSHDSACASA-N,
o-ANISAMIDE, N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-5-SULFAMOYL-, (S)-(-)-,
HMS2051A08,
HMS2089E04,
HMS2232P10,
HMS3263I20,
HMS3266P14,
HMS3675D20,
HY-B1059,
Tox21_110933,
Tox21_501089,
ANW-42196,
BG0325,
CL-004,
GP2472,
PDSP1_000516,
PDSP1_000620,
PDSP1_001649,
PDSP2_000514,
PDSP2_000616,
s2104,
SBB058180,
AKOS007930553,
AKOS015897363,
Tox21_110933_1,
AC-6821,
API0003164,
BCP9000853,
CCG-100847,
CS-4581,
KS-5103,
LP01089,
NC00097,
NCGC00015966-10,
NCGC00016718-01,
NCGC00024853-01,
NCGC00024853-02,
NCGC00024853-03,
NCGC00024853-04,
NCGC00024853-06,
NCGC00024853-09,
NCGC00261774-01,
CC-29928,
CPD000466366,
SAM001246703,
SC-76846,
BCP0726000072,
AB1009626,
CAS_15676-16-1,
TL8001954,
(S)-(-)-Sulpiride, >=98% (titration),
EU-0101089,
I0821,
ST50319539,
SW197477-2,
D07312,
K-6442,
S 7771,
AB00639965-06,
AB00639965-08,
AB00639965_09,
672L073,
C-20361,
SR-01000076136,
SR-01000597436,
J-015181,
SR-01000076136-2,
SR-01000597436-1,
BRD-K51671335-001-01-5,
BRD-K51671335-001-04-9,
(S)-(-)-Sulpiride, VETRANAL(TM), analytical standard,
UNII-7MNE9M8287 component BGRJTUBHPOOWDU-NSHDSACASA-N,
(-)-N-[(1-Ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-o-anisamide,
(-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide,
5-(Aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-benzamide,
5-(Aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy-benzamide,
Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, (S)- (9CI),
5-HT6 Serotonin Receptor from rat, recombinant, expressed in HEK 293 cells, membrane suspension,
sulpiride,
lesuride,
null,
Levosulpiride?,
Levosulpiride [INN],
Levosulpiride (INN),
Levosulpiridum [INN-Latin],
Levosulpirida [INN-Spanish],
(RS)-(+/-)-sulpiride,
ACN-S005456,
C15-H23-N3-O4-S,
CID688272,
CS-O-01769,
B1484,
C078143,
N-(((S)-1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide,
(S)-(-)-Sulpiride, 98%, a selective antagonist for D2 dopamine receptor - 25G 25g,
Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, (S)-,
15676-16-1,
|
| Complexity | 505 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 341.141g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 23 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 341.426g/mol |
| Monoisotopic Mass | 341.141g/mol |
| Rotatable Bond Count | 6 |
| Topological Polar Surface Area | 110A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 0.6 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code | \N |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

